+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug-Device Combination Products Market - Global Forecast 2025-2030- Product Image
Drug-Device Combination Products Market - Global Forecast 2025-2030- Product Image
Sale

Drug-Device Combination Products Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715527
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The drug-device combination products market is entering a period of accelerated evolution as healthcare environments increasingly prioritize safety, regulatory efficiency, and smart therapeutic solutions. Senior leaders across pharmaceuticals, devices, and supply chain should evaluate the competitive landscape and emerging opportunities in this complex, converging sector.

Market Snapshot: Drug-Device Combination Products

Spanning advanced therapies and integrated care tools, the drug-device combination products market demonstrated notable growth, reaching USD 144.59 billion in 2024 before rising to USD 156.46 billion in 2025. Forecasts indicate an ongoing compound annual growth rate of 8.14%, with the sector projected to achieve USD 231.25 billion by 2030. This expansion is driven by clinical demand for precision, operational efficiency, and real-time data integration. Drug-device combinations are setting new standards by allowing targeted delivery and continuous patient monitoring, positively influencing clinical pathways and payer outcomes.

Scope & Segmentation of the Drug-Device Combination Products Market

This research comprehensively analyzes the structure and direction of the market across technologies, end users, and regional landscapes, providing targeted insights for strategic planning and market entry.

  • Product Types: Drug-eluting stents, inhalers, injector systems (auto-injectors, needle-free injectors), prefilled syringes and pens, topical medicines, transdermal patches
  • Technology: Advanced release technologies, biodegradable technology, conventional device-drug technology, smart device technologies (automatic dosing, digital monitoring)
  • Dosage Forms: Liquid, semi-solid (creams, ointments, powders), and solid (capsules, tablets)
  • Therapeutic Classes: Cardiovascular medications, diabetes and endocrinology, hormonal replacement therapy, oncology drugs (chemotherapy, participatory oncology treatment), and pain management
  • End Users: Ambulatory surgical centers, homecare settings, hospitals and clinics, specialty clinics
  • Regions: Coverage includes detailed analysis across the Americas (United States—with emphasis on key states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the United Kingdom, Germany, France, Russia, Italy, Spain, and a broad range of EMEA economies), and Asia-Pacific (covering China, India, Japan, Australia, South Korea, Southeast Asia, and other leading APAC nations)
  • Key Players: Analysis of major industry participants including Abbott Laboratories, Medtronic PLC, Boston Scientific, Fresenius Kabi, Novartis AG, and over 20 others, highlighting partnerships and innovation strategies

Key Takeaways for Senior Decision-Makers

  • Integrated drug-device platforms are advancing therapeutic precision, enabling healthcare providers to tailor treatments and enhance adherence through automated dosing and real-time monitoring.
  • Collaboration between pharmaceutical and device manufacturers is accelerating R&D pipelines, allowing stakeholders to co-create hybrid solutions and diversify market positioning.
  • Emerging device features such as biodegradable polymers, microneedle arrays, and digital tracking are minimizing clinical invasiveness while maximizing safety and ease of use for patients.
  • Regional market differences, including regulatory harmonization and production scalability, play a critical role in shaping growth trajectories and investment priorities between the Americas, EMEA, and Asia-Pacific.
  • Supply chain agility and ongoing regulatory adaptation are essential for mitigating risks associated with evolving trade environments and reimbursement frameworks.

Tariff Impact: 2025 Supply Chain and Cost Implications

The introduction of new United States tariffs in early 2025 has heightened cost pressures on sourcing and assembly for drug-device combination products. These measures have prompted manufacturers to reevaluate supplier and component strategies, leading to increased domestic partnerships and selective relocation of production to manage cost escalations and maintain competitive pricing. Ultimately, these shifts are redefining supply chain architectures and resilience across the sector.

Methodology & Data Sources

The research foundation combines expert interviews from device engineers, regulatory consultants, and supply chain specialists with critical reviews of regulatory filings, peer-reviewed journals, and patent databases. Data triangulation and expert validation workshops ensure consistency, depth, and actionable relevance in every analytical conclusion.

Why This Report Matters

  • Supports investment, development, and risk management decisions by illuminating how evolving technology, regulations, and tariffs are shaping the drug-device combination products landscape.
  • Enables leaders to benchmark their innovation, supply chain, and partnership initiatives against market trends and competitive moves across core regions.
  • Assists stakeholders in identifying high-value opportunities for new product launches, market entry, and regulatory planning by providing detailed segmentation and regional perspectives.

Conclusion

The drug-device combination products market is rapidly redefining how therapies are delivered and monitored globally. Senior executives who proactively align with technological advances and regional shifts will drive stronger clinical and commercial impact in this evolving arena.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of wearable drug delivery patches with integrated digital monitoring capabilities
5.2. Rising adoption of connected inhaler devices for remote respiratory therapy adherence tracking
5.3. Regulatory harmonization efforts accelerating approvals for combination product submissions globally
5.4. Integration of artificial intelligence in on-device diagnostics for personalized dosing optimization
5.5. Development of biodegradable implantable drug-eluting microsensors for targeted therapy feedback
5.6. Emergence of user-centered design in smart injection pens to improve patient self-administration
5.7. Collaborative partnerships between biotech firms and device manufacturers to co-develop novel biologic delivery systems
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Drug-Device Combination Products Market, by Product Type
8.1. Introduction
8.2. Drug-Eluting Stents
8.3. Inhalers
8.4. Injector Systems
8.4.1. Auto-Injectors
8.4.2. Needle-Free Injectors
8.5. Prefilled Syringes & Pens
8.6. Topical Medicines
8.7. Transdermal Patches
9. Drug-Device Combination Products Market, by Technology
9.1. Introduction
9.2. Advanced Release Technologies
9.3. Biodegradable Technology
9.4. Conventional Device-Drug Technology
9.5. Smart Device Technologies
9.5.1. Automatic Dosing
9.5.2. Digital Monitoring
10. Drug-Device Combination Products Market, by Dosage Form
10.1. Introduction
10.2. Liquid Dosage Forms
10.3. Semi-Solid Dosage Forms
10.3.1. Creams
10.3.2. Ointments
10.3.3. Powders
10.4. Solid Dosage Forms
10.4.1. Capsules
10.4.2. Tablets
11. Drug-Device Combination Products Market, by Therapeutic Class
11.1. Introduction
11.2. Cardiovascular Medications
11.3. Diabetes & Endocrinology
11.4. Hormonal Replacement Therapy
11.5. Oncology Drugs
11.5.1. Chemotherapy
11.5.2. Participatory Oncology Treatment
11.6. Pain Management
12. Drug-Device Combination Products Market, by End-User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Homecare Settings
12.4. Hospitals and Clinics
12.5. Specialty Clinics
13. Americas Drug-Device Combination Products Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Drug-Device Combination Products Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Drug-Device Combination Products Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. AbbVie Inc.
16.3.3. B. Braun SE
16.3.4. Baxter International Inc.
16.3.5. Becton, Dickinson and Company
16.3.6. BIOTRONIK SE & Co. KG
16.3.7. Boston Scientific Corporation
16.3.8. Braile Biomédica
16.3.9. Cardinal Health, Inc.
16.3.10. CODAN Companies
16.3.11. Cook Group Incorporated
16.3.12. F. Hoffmann-La Roche Ltd.
16.3.13. Fresenius Kabi
16.3.14. ICU Medical, Inc.
16.3.15. InSitu Technologies Inc.
16.3.16. JMS North America Corporation
16.3.17. Lepu Medical Technology Company
16.3.18. Medtronic PLC
16.3.19. MicroPort Scientific Corporation
16.3.20. Novartis AG
16.3.21. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
16.3.22. SOOIL Developments Co., Ltd.
16.3.23. Stryker Corporation
16.3.24. Teleflex Incorporated
16.3.25. Terumo Group
16.3.26. Viatris Inc.
16.3.27. W. L. Gore & Associates Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DRUG-DEVICE COMBINATION PRODUCTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. DRUG-DEVICE COMBINATION PRODUCTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. DRUG-DEVICE COMBINATION PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. DRUG-DEVICE COMBINATION PRODUCTS MARKET: RESEARCHAI
FIGURE 26. DRUG-DEVICE COMBINATION PRODUCTS MARKET: RESEARCHSTATISTICS
FIGURE 27. DRUG-DEVICE COMBINATION PRODUCTS MARKET: RESEARCHCONTACTS
FIGURE 28. DRUG-DEVICE COMBINATION PRODUCTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DRUG-DEVICE COMBINATION PRODUCTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DRUG-ELUTING STENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DRUG-ELUTING STENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INHALERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INHALERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PREFILLED SYRINGES & PENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PREFILLED SYRINGES & PENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TOPICAL MEDICINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TOPICAL MEDICINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ADVANCED RELEASE TECHNOLOGIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ADVANCED RELEASE TECHNOLOGIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY BIODEGRADABLE TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY BIODEGRADABLE TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CONVENTIONAL DEVICE-DRUG TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CONVENTIONAL DEVICE-DRUG TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AUTOMATIC DOSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AUTOMATIC DOSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DIGITAL MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DIGITAL MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY LIQUID DOSAGE FORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY LIQUID DOSAGE FORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CREAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY OINTMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY POWDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY POWDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CARDIOVASCULAR MEDICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CARDIOVASCULAR MEDICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DIABETES & ENDOCRINOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DIABETES & ENDOCRINOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HORMONAL REPLACEMENT THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HORMONAL REPLACEMENT THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PARTICIPATORY ONCOLOGY TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PARTICIPATORY ONCOLOGY TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 139. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 142. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 143. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 144. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 145. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2024 (USD MILLION)
TABLE 146. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2025-2030 (USD MILLION)
TABLE 147. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 148. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 149. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 150. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 151. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 152. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 153. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 154. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 155. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2024 (USD MILLION)
TABLE 156. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2025-2030 (USD MILLION)
TABLE 157. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 158. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 159. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 162. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 163. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2024 (USD MILLION)
TABLE 166. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2025-2030 (USD MILLION)
TABLE 167. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 168. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 169. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 172. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 173. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 174. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2025-2030 (USD MILLION)
TABLE 177. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 178. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 261. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 264. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 265. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 266. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 267. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2024 (USD MILLION)
TABLE 268. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2025-2030 (USD MILLION)
TABLE 269. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 270. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 271. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 272. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 273. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 274. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 275. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 276. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 277. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2024 (USD MILLION)
TABLE 278. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2025-2030 (USD MILLION)
TABLE 279. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 280. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 281. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 284. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 285. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 286. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 287. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2024 (USD MILLION)
TABLE 288. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2025-2030 (USD MILLION)
TAB

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Drug-Device Combination Products market report include:
  • Abbott Laboratories
  • AbbVie Inc.
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Braile Biomédica
  • Cardinal Health, Inc.
  • CODAN Companies
  • Cook Group Incorporated
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Kabi
  • ICU Medical, Inc.
  • InSitu Technologies Inc.
  • JMS North America Corporation
  • Lepu Medical Technology Company
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Novartis AG
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • SOOIL Developments Co., Ltd.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Group
  • Viatris Inc.
  • W. L. Gore & Associates Inc.

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 156.46 Billion
Forecasted Market Value ( USD ) by 2030 $ 231.25 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Drug Device Combination Products Market by Type (Injectable, Transdermal Patch, Infusion Pump, Drug-eluting Stent, Inhaler), Application (Diabetes, Oncology, Pain, Opthamology), End User (Hospital, Home Care), and Region - Global Forecast to 2030 - Product Image

Drug Device Combination Products Market by Type (Injectable, Transdermal Patch, Infusion Pump, Drug-eluting Stent, Inhaler), Application (Diabetes, Oncology, Pain, Opthamology), End User (Hospital, Home Care), and Region - Global Forecast to 2030

  • Report
  • 346 Pages
  • Global
From
Drug Device Combination Market Report 2025 - Product Image

Drug Device Combination Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Motion Sickness Treatment Market - Global Forecast 2025-2030 - Product Image

Motion Sickness Treatment Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Drug Device Combination Products Market Report by Product, Application, End User, and Region 2024-2032 - Product Image

Drug Device Combination Products Market Report by Product, Application, End User, and Region 2024-2032

  • Report
  • 136 Pages
  • Global
From
Drug Device Combination Products - Global Strategic Business Report - Product Image

Drug Device Combination Products - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.